Minutes from meeting 9th March 2000 at KPLL, Copenhagen and later elaboration

Present: Peter Felding, Per Hyltoft Petersen, Per Simonsson, Arne Mårtensson, Elin Olavsdottir, Ivan Brandslund + secretary, Nils Jørgensen, Veli Kairisto, Ari Lahti, Pål Rustad.

Responsible for minutes:

Data registration and responsibilities for data treatment: Pål Rustad

Quality goals, exclusion criteria and reference interval calculation: Per Hyltoft Petersen, Veli Kairisto, Ari Lahti.

 

Data registration and responsibilities for data treatment

Introduction, data registration

Responsibility for definition of the relational data base: Pål Rustad.

Responsibility for interface between the participating laboratories and the data base: Ivan Brandslund.

The intention for registration of data is that each participating laboratory shall register data on sample collection tubes, reference persons, analytical methods, and analytical results. Method data should be in accordance with the method codes used by Labquality.

In Turku June 98 the idea of letting the laboratories use the ROAN server on internet to register all data produced for the project was discussed with Ivan Brandslund. A preliminary definition of the data base was presented at that moment.

As the project progressed it was necessary to modify the data base to allow for registration of serum and plasma results for the same reference individual and redefinition of tables on method data according to data transmitted from Labquality. These data were transmitted to Brandslund Autumn 1999.

Meeting

The definition of the data base as described to Ivan Brandslund before, was distributed and discussed.

Conclusions

Responsibility for:

- excluding analytical data according to criteria based on exclusion criteria for reference persons and quality goals: Nils Jørgensen.

- calculating reference intervals, also evaluating necessity for division into subgroups (gender, age etc.) influencing : Veli Kairisto, Ari Lahti

The registration program should be finished late April.

At the present (30/5-00) it is decided that a registration program should be loaded from internet, the laboratory shall register the data and then send the data to the data base by E-mail. Instructions for use will be incorporated into the registration program. Pål Rustad and Peter Felding shall receive a prototype for evaluation.

 

Quality goals, exclusion criteria and reference interval calculation

Conclusions from the meeting at KPLL (9th March 2000) and later elaboration by Ari, Veli and Per.

These, are not the minutes from the meeting, but the best, the three of us, could agree on during the meeting and as a result of the following correspondence in March.

Introduction

These are the general principles, outlined before any data are available from the project.

There may be results and conditions, for which other approaches are necessary, e.g., for S/P-Sodium, where more pragmatic approaches are used.

In general, any specification below 1 % is unrealistic, and will be considered as 1%.

The theories for analytical specifications and estimation of reference intervals are, with some modifications, based on references 1 - 9.

Reference preparation, calibrator and controls

There are the following materials:

CAL

The reference preparation with target values traceable to reference methods (Target values transferred by the German control organisation)

X

The secondary calibrator (serum pool based on serum from men)

P

The principle control (serum pool from women using estrogen)

HIGH

Concentrated serum pool

LOW

The High-pool diluted 1 + 1 with Na-Ca-solution

The assignment of concentration values to X, P, High, and Low takes place during the project by use of the data from selected laboratories. For High and Low, the ratio High/Low should be 2.0 (lower for Na and Ca).

Analytical quality specifications for producing reference values

The ideal specifications for producing reference values to the common reference intervals can not be based on the final product of the project (which does not exist at the moment), and must therefore, be based on well documented existing reference intervals. These are chosen to be the reference intervals from Malmö-Trelleborg (Per Simonsson), and when only upper reference limit is defined, the data from Fyns Amt are used.

For X and P, the ideal analytical specifications for mean values should be 0.125*s (corresponding to the ‘optimum’ specifications and ignoring that the distribution hardly is Gaussian), where s is defined as 0.25 times the reference range, e.g., for P-Alkaline Phosphatases the reference interval is 0.8 to 4.6 μkat/L (range 3.8), where the specification for maximal bias is ½bias½ £ 0.125*0.25*3.8 » 0.12 (corresponding to approx. 4.5 %). However, for P-Potassium, the reference interval is 3.2 - 4.7 mmol/L, where the specification for maximum allowable bias is ½bias½ £ 0.125*0.25*1.5 » 0.05 mmol/L, which with only one decimal is changed to 0.1 mmol/L (corresponding to approx. 2.5 %). Regarding the analytical imprecision, most methods have within-run CV-values below 2 %, which is considered sufficient, except from Sodium and Calcium, where 1 % is needed.

When the log-Gaussian distributions are assumed, the ratio between upper and lower reference limits are computed and the specifications are read off from a diagram. Thus the enzyme P-Alkaline Phosphatases can be assumed log-Gaussian and the ratio is 5.75, which corresponds to an allowable analytical bias of approximately ± 6 % for imprecision below 3 %, which is a little larger than for the Gaussian assumption. For narrow intervals, the two models approach each other.

The allowable deviations from 2.0 for the ratio between High and Low is practically independent of the reference intervals, and can therefore, be defined equal for all components (except from Na and Ca) as if the ratio between high and low reference limits were 2.0. This corresponds to ± 2.5 % and to the interval 1.95 to 2.05. (In principle this should be multiplied with 2½, but there is no calibration error in this ratio, so this element should be taken out of the specification).

Analytical quality specifications for using the common reference intervals

The specifications will be based on the new created reference intervals. It is of course possible to use the common reference intervals anyway, but we recommend ½bias½ £ 0.25*s (desirable quality) with a maximum of ½bias½ £ 0.375*s (minimum quality). For the two examples the values are: for P-Alkaline Phosphatases: desirable ½bias½ £ 0.25*0.25*3.8 » 0.24 (corresponding to approx.10 %). For P-Potassium the specification for maximal bias is ½bias½ £ 0.25*0.25*1.5 » 0.1 mmol/L (desirable), which corresponds to approx. 2.5 %, or 0.375*0.25*1.5 » 0.1.5 mmol/L (minimum) Þ 0.2 mmol/L, which corresponds to 5 %. Now the limits for CV are valid for total CVAnalytical, corresponding to 4 % and 2 %, respectively.

The specifications for ratio of controls is the double of the above mentioned, i.e. ± 5 %

These specifications are related to the use of the common reference intervals, and not to other specifications for the analytical quality, e.g., clinically derived specifications, accreditation, etc.

Specifications for acceptance of reference individuals

The primary concept is to sort out the individuals not suited as reference individuals based on the questionnaire, but as people may give wrong answers or suffer from diseases they are unaware of, some extra ‘rule out’ criteria are needed. These criteria are (based on the assumption that a reference interval covers 4*s) are (i) one or more values outside M ± 4*s and (ii) two or more values outside M ± 3*s.

Production of reference intervals

The basic principle is to make the common reference intervals as simple as possible, i.e. one single interval, if no subgroup (of a reasonable size) differs by more than a defined distance.

Crude model

This first evaluation is a non-parametric calculation of 2.5 and 97.5 percentiles (after ranking of all reference values (crude reference interval)). Then, the reference interval for each relevant subgroup is calculated (for smaller groups calculated based on Gaussian or log-Gaussian models) and compared with the crude interval. If the difference between limits exceed 0.25*s (Gaussian or log-Gaussian), then an other calculation model will be used. If the subgroup(s) under consideration has no logical basis - where a logical basis could be gender - but, e.g., males between 30 and 40, this may be ignored. The single common reference interval is then the crude interval with confidence intervals for the limits based on non-parametric calculations. If the distribution(s) are clearly Gaussian or log-Gaussian, parametric treatment of data can be performed as well. For both parametric and nonparametric reference limits, confidence intervals will be calculated using established statistical methods.

Logical based subgroups

Division into subgroups by gender or pre- and post-menopausal women and ± estrogenes is considered a logical sub-grouping with logical subgroups. If these subgroups differ from the crude model, they are treated separately, but each according to the crude model, if reasonably large (> 250). As primary criteria for division into subgroups the following attributes of the reference persons will be considered: gender, age, use of estrogens, preanalytical fasting time, country of origin. The need for separate reference intervals for various sample materials (fresh plasma, fresh or frozen serum) will be evaluated using the same statistical criteria as those used for division into subgroups.

Regression-based reference limits

If the division into subgroups indicates correlation between an attribute, such as age or fasting time, and an analyte, regression-based reference limits will be considered. A regression model will be adopted if the R2 of the model exceeds 10 %. Confidence intervals for the regression-based reference limits will be calculated, as well, using the method described by Virtanen et al. (8).

Presentation

The presentation of common reference intervals may include all three levels - if the crude model is insufficient in describing all relevant aspects of the reference values.

Discussion

All these calculations are theoretically, and if the concept does not fit into the data from the project, the whole concept must be reconsidered.

References

  1. Solberg HE. Approved recommendation (1987) on the theory of reference values. part 5. Statistical treatment of collected reference values: Determination of reference limits. J Clin Chem Clin Biochem 1987;25:6445-56.
  2. Gowans EMS, Hyltoft Petersen P, Blaabjerg O, Hørder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988;48:757-64.
  3. Hyltoft Petersen P, Gowans EMS, Blaabjerg O, Hørder M. Analytical goals for the estimation of non-Gaussian reference intervals. Scand J Clin Lab Invest 1989;49:727- 37.
  4. Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990;36:265-70.
  5. Fraser CG, Hyltoft Petersen P, Ricos C, Haeckel R. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. Eur Clin Chem Clin Biochem 1992;30:311-7.
  6. Stöckl D, Baadenhuijsen H, Fraser CG, Libeer J-C, Hyltoft Petersen P, Ricós C. Desirable routine analytical goals for quantities assayed in serum. Discussion paper from the members of the external quality assessment (EQA) working group A on analytical goals in laboratory medicine. Eur J Clin Chem Clin Biochem 1995;33:157- 69.
  7. Hyltoft Petersen P, Blaabjerg O. Reference Intervals for Plasma Proteins. Principles for Estimation of Reference Intervals. In Assessing Quality in Measurements of Plasma Proteins. The Nordic Protein Project and Related Projects (eds. Hyltoft Petersen P, Blaabjerg O, Irjala K). NORDKEM. Nordic Clinical Chemistry Project, Helsinki, Finland 1994:117-23.
  8. Virtanen, A., Kairisto, V., Irjala, K., Rajamäki, A., Uusipaikka, E. Regression-based reference limits and their reliablility: example on hemoglobin during the first year of life. Clin. Chem. 1995; 44/2: 327-335.
  9. Fraser CG, Hyltoft Petersen P, Libeer J-C, Ricós C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8-12.